16 Panel Dip Card
The 16 panel dip card is a fast, reliable, and easy-to-use urine screening device designed to
detect ten commonly abused drugs in a single test format. This multi-drug detection dip card
is widely used in workplaces, rehabilitation programs, probation monitoring, healthcare screening,
law enforcement, and personal testing where accurate and efficient drug screening is required.
Showing all 3 results
Dip card 16 Panel Detecting TCA, KRA, FEN & ETG, Short Date Sale, experation Date 12/13/26, As low as $0.99
AMP, BAR, BUP, BZO, COC, EtG, FEN, KRA, MDMA, MET, MTD, OPI/MOR, OXY, PCP, TCA, THCForensic UseAs low As$ 0.99 $0.99 - $1.23
Dip card 16 Panel Detects Kratom, Ketamine, ETG and Fentanyl, As low as $1.69
AMP, BAR, BUP, BZO, COC, EtG, FEN, KET, KRA, MDMA, MET, MTD, OPI/MOR, OXY, PCP, THCForensic UseAs low As$1.59 $1.59 - $1.99
Dip card 16 Panel Detects K2, ETG, FEN, PCP & TRA, Serenity Multi-Level Dip Card
AMP, BAR, BUP, BZO, COC, EtG, FEN, K2, MDMA, MET, MTD, OPI/MOR, OXY, PCP, THC, TRAForensic UseAs low As$1.59 $1.59 - $1.99
Bulk Pricing that Cuts the Budget in Half
Priority Shipping For Bulk Orders.
Dedicated Wholesale Representative.
Quality That Is Reliable For the Nation.
Key Features of 16 Panel Dip Card
- Non-invasive collection – saliva sample only, no urine or blood required
- Rapid results – preliminary screening complete in 5 to 10 minutes for 6 types of drugs and variants
- Fully observed collection – tamper-resistant process with no restroom needed
- On-site ready – no lab, no special equipment, no collection facility required
- Detects recent use – identifies drug use within the past 24 to 48 hours
- Minimal training required – straightforward administration for any staff member
- Individually sealed sterile devices – hygienic single-use packaging for every test
16 Panel Multi Dip Card Test specifications
| Code | Full Substance Name | Cutoff | What It Catches |
|---|---|---|---|
| AMP | Amphetamines | 1000 ng/mL | Adderall, Vyvanse, prescription and illicit amphetamines — standard on all three cards |
| BAR | Barbiturates | 300 ng/mL | Phenobarbital, butalbital, secobarbital — standard on all three cards |
| BUP | Buprenorphine | 10 ng/mL | Suboxone, Subutex — detects MAT compliance at therapeutic concentrations a standard OPI strip misses — standard on all three cards |
| BZO | Benzodiazepines | 300 ng/mL | Xanax, Valium, Klonopin, Ativan — standard on all three cards |
| COC | Cocaine | 300 ng/mL | Cocaine, crack cocaine — standard on all three cards |
| EtG | Ethyl Glucuronide | 300 ng/mL | Alcohol metabolite up to 80 hours post-consumption — standard on all three cards |
| FEN | Fentanyl | 20 ng/mL | Illicit fentanyl and primary fentanyl analogs — SAMHSA federal mandate July 2025 — standard on all three cards |
| K2 | Synthetic Cannabinoids | 50 ng/mL | K2, Spice — does not cross-react with THC — present only on K2/TRA card |
| KET | Ketamine | 1000 ng/mL | Special K, ketamine — dissociative anesthetic, not detected on any standard panel — present only on KET/KRA card |
| KRA | Kratom | 500 ng/mL | Mitragyna speciosa — opioid receptor activity, passes all OPI/BUP/MTD panels — present on TCA/KRA and KET/KRA cards |
| MDMA | MDMA / Ecstasy | 500 ng/mL | Ecstasy, Molly — independent dedicated panel — standard on all three cards |
| MET | Methamphetamine | 1000 ng/mL | Crystal meth, street methamphetamine — standard on all three cards |
| MTD | Methadone | 300 ng/mL | Methadone maintenance — does not appear on standard OPI strip — standard on all three cards |
| OPI/MOR | Opiates / Morphine | 300 ng/mL | Heroin, codeine, morphine — standard on all three cards |
| OXY | Oxycodone | 100 ng/mL | OxyContin, Percocet — does not appear on standard OPI strip — standard on all three cards |
| PCP | Phencyclidine | 25 ng/mL | PCP, angel dust — standard on all three cards |
| TCA | Tricyclic Antidepressants | 1000 ng/mL | Amitriptyline, nortriptyline, doxepin — present only on TCA/KRA card |
| THC | Marijuana / Cannabis | 50 ng/mL | Cannabis, edibles, concentrates — standard on all three cards |
| TRA | Tramadol | 1000 ng/mL | Ultram — prescription opioid not detected by standard OPI panels — present only on K2/TRA card |
Red codes appear on only one or two of the three configurations. EtG and FEN are the two constant specialty additions over the standard 12 panel baseline across every card. See variant table below for which card includes which panels.
Choose Your 16 Panel Configuration
| Product | All 16 Panels | Type | From |
|---|---|---|---|
| 16 Panel with TCA, KRA, EtG and FEN SHORT DATE SALE — Expiry 12/13/26 Best for pain management, MAT, forensic programs with TCA and Kratom requirements |
AMP | BAR | BUP | BZO | COC EtG/300ng | FEN/20ng | KRA/500ng | TCA/1000ng MDMA | MET | MTD | OPI/MOR | OXY | PCP | THC |
Forensic Use Only | $0.99 Short Date |
| 16 Panel with KRA, KET, EtG and FEN Best for treatment, corrections, harm reduction programs needing Kratom and Ketamine detection |
AMP | BAR | BUP | BZO | COC EtG/300ng | FEN/20ng | KET/1000ng | KRA/500ng MDMA | MET | MTD | OPI/MOR | OXY | PCP | THC |
Forensic Use Only | $1.59 |
| 16 Panel with K2, TRA, EtG and FEN Best for corrections, sober living, forensic programs needing K2 and Tramadol alongside the full baseline |
AMP | BAR | BUP | BZO | COC EtG/300ng | FEN/20ng | K2/50ng | TRA/1000ng MDMA | MET | MTD | OPI/MOR | OXY | PCP | THC |
Forensic Use Only | $1.59 |
All three cards require a separate urine collection container. Results in 5 minutes. 99% accuracy. Forensic Use Only — all presumptive positive results require GC-MS or LC-MS/MS confirmation. Short Date Sale card (TCA/KRA, $0.99) expires 12/13/26 — verify expiry before ordering. For bulk pricing call 561-897-9238 or email [email protected].
Easy Steps To Use The 16 Panel Dip Card
Step 1 — Collect
Remove the drug test cup from its sealed pouch and use it as soon as possible. Have the subject provide a urine sample directly into the cup, filling to the indicated line.
Step 2 — Dip & Wait
At 2–4 minutes, verify the temperature of the specimen using the built-in temperature strip. A green indicator confirms the sample is valid and within the acceptable range of 90–100°F.
Step 3 — Read
Peel back the label when ready to interpret results. Read results within 5 minutes of collection. Do not read results after 8 minutes, as the extended window may affect accuracy.
Positive
Two colored bands appear — one in the control region (C) and one in the test region (T). This indicates no drug was detected above the cutoff level.
Negative
Two colored bands appear, one in the control region (C) and another in the test region (T) for the drug in question.
Invalid
The control band fails to appear entirely. Discard the test and retest with a fresh cup within 3 minutes. If the problem persists, contact your distributor.
What is Included in a 16 Panel Dip Card?
The 16 panel dip card category from 12 Panel Now contains three distinct Serenity Multi-Level Dip Cards sharing 14 common panels and adding two distinct specialty substances per card. The 14 common panels across all three are AMP, BAR, BUP, BZO, COC, EtG, FEN, MDMA, MET, MTD, OPI/MOR, OXY, PCP, and THC. Each card then adds exactly two specialty panels to reach 16 total. All three are Forensic Use Only. The TCA/KRA configuration is currently available at $0.99 as a short-date sale (expiry 12/13/26). The KET/KRA and K2/TRA configurations are at $1.59 in standard stock.
What separates the three 16 panel configurations:
16 Panel with TCA, KRA, EtG and FEN — SHORT DATE SALE $0.99
Unique to this card: TCA/1000ng + KRA/500ng alongside EtG, FEN, and the full 14-panel baseline. Expiry 12/13/26
This configuration adds Tricyclic Antidepressants (TCA) at 1000 ng/mL and Kratom (KRA) at 500 ng/mL to the 14-panel baseline. TCA covers amitriptyline, nortriptyline, and doxepin — prescription antidepressants monitored in pain management protocols and specified in some court supervision orders. Kratom acts on mu-opioid receptors but does not cross-react with any OPI, BUP, or MTD panel — the dedicated KRA panel at 500 ng/mL provides the only available rapid urine detection. At $0.99 per card this is the most cost-effective 16 panel configuration in the range. The short date of 12/13/26 makes it appropriate for programs ordering to use within this timeframe. Contact 12 Panel Now to confirm current stock availability at the $0.99 price before placing bulk orders.
16 Panel with KRA, KET, EtG and FEN — $1.59
Unique to this card: KET/1000ng + KRA/500ng alongside EtG, FEN, and the full 14-panel baseline
This configuration adds Ketamine (KET) at 1000 ng/mL and Kratom (KRA) at 500 ng/mL to the 14-panel baseline — two substances that currently pass every standard multi-panel test. Ketamine is a DEA Schedule III dissociative anesthetic increasingly misused recreationally (as Special K) and prescribed for treatment-resistant depression. No standard panel detects ketamine because it does not cross-react with PCP, BZO, or any other standard antibody. KRA at 500 ng/mL provides Kratom detection. Together these two additions close the two most frequently documented non-opioid, non-stimulant detection gaps in treatment programs dealing with polydrug use involving legal and clinical substances. EtG and FEN complete the four specialty panels across the 16 total.
16 Panel with K2, TRA, EtG and FEN — $1.59
Unique to this card: K2/50ng + TRA/1000ng alongside EtG, FEN, and the full 14-panel baseline
This configuration adds K2 Synthetic Cannabinoids at 50 ng/mL and Tramadol (TRA) at 1000 ng/mL to the 14-panel baseline. K2 does not cross-react with the THC antibody — a specimen from a K2 user returns a negative THC result at any THC cutoff level. TRA (Ultram) is a prescription opioid that does not trigger any standard OPI, OXY, BUP, or MTD panel due to its distinct molecular structure. Per NIDA K2/Spice research, synthetic cannabinoids are documented in correctional and residential recovery settings. Per NIDA prescription misuse data, tramadol misuse is documented in forensic and treatment populations. This card is the appropriate choice for programs where K2 institutional contraband and tramadol diversion are both documented concerns alongside the standard substance baseline, alcohol monitoring, and fentanyl detection.
The Structure of the 16 Panel Dip Card Range: 14 Common Panels, Two Specialty Additions Per Card
Every 16 panel card starts from the same 14-panel foundation and adds two specific substances to reach 16. EtG and FEN are already within those 14 common panels. The two remaining specialty additions per card are: TCA + KRA, KET + KRA, or K2 + TRA. Programs that need multiple specialty panels not available on a single card can run two cards from the same specimen — for example, running the KRA/KET card and the K2/TRA card from the same collection to cover KRA, KET, K2, and TRA simultaneously. For higher panel count configurations integrating all these substances in a single card, see the 19 panel dip card range.
16 Panel Dip Card Features: EtG and FEN on Every Card, Kratom on Two, Ketamine, TCA, K2 and Tramadol Across Three Configurations from $0.99
Three 16 Panel Drug Test Dip Cards from 12 Panel Now: EtG and FEN Standard, Three Specialty Panel Combinations at $0.99 and $1.59 in Bulk: The 16 panel dip card range delivers 14 common panels including EtG/300 for alcohol monitoring and FEN/20 for fentanyl detection across all three configurations, then adds two specific specialty substances per card to cover TCA and Kratom, Ketamine and Kratom, or K2 and Tramadol.
- TCA/KRA Card at $0.99 Short Date: Tricyclic Antidepressant and Kratom Detection for Pain Management and MAT Programs: The 16 Panel TCA/KRA card at $0.99 (short date 12/13/26) adds TCA at 1000 ng/mL for tricyclic antidepressant monitoring and KRA at 500 ng/mL for Kratom detection alongside EtG, FEN, PCP, BAR, and the complete opioid and stimulant baseline. For pain management programs co-prescribing TCAs alongside opioids, and for MAT programs where patients use Kratom as an opioid substitute, this card covers both gaps for under $1 per card during the short date sale period.
- KET/KRA Card at $1.59: The Only 16 Panel Card Covering Both Ketamine and Kratom Alongside EtG and FEN: The KET/KRA configuration adds Ketamine at 1000 ng/mL and Kratom at 500 ng/mL. Both are substances increasingly documented in treatment populations — Ketamine as a clinically prescribed antidepressant and as a misused recreational substance, Kratom as a legal self-managed opioid substitute. Neither appears on any standard multi-panel test. For programs dealing with polydrug use involving both Ketamine and Kratom alongside fentanyl supply contamination and alcohol monitoring, this single card covers all four specialty needs at $1.59.
- K2/TRA Card at $1.59: Synthetic Cannabinoid and Tramadol Detection for Corrections and Forensic Programs: The K2/TRA configuration adds K2 Synthetic Cannabinoids at 50 ng/mL and Tramadol at 1000 ng/mL. K2 is documented institutional contraband that passes every THC panel. Tramadol is a prescription opioid that passes every OPI, OXY, BUP, and MTD panel. Both are extensively documented as forensic screening gaps. For correctional facilities and forensic supervision programs where both K2 institutional use and tramadol diversion are documented alongside alcohol and fentanyl monitoring requirements, the K2/TRA card is the single-card solution at $1.59.
- Kratom on Two of Three Cards: The Most Requested Specialty Panel in the 16 Panel Range: Kratom (KRA) at 500 ng/mL appears on both the TCA/KRA card and the KET/KRA card — the two most commonly selected configurations for programs dealing with opioid-adjacent populations. Kratom's mu-opioid receptor activity combined with its legal retail availability in most US states makes it the single most significant undetected substance in MAT and treatment populations, according to NIDA herbal drug research.
- EtG and FEN Standard on All Three: Alcohol and Fentanyl Monitoring Regardless of Configuration: Every 16 panel card includes EtG at 300 ng/mL for 80-hour alcohol monitoring and FEN at 20 ng/mL for fentanyl detection per the July 2025 SAMHSA federal mandate. No configuration selection is required for these two capabilities — they are delivered as standard on every card in the range.
- From $0.99 Short Date and $1.59 Standard, Same-Day Shipping, 10% Price Beat Guarantee: Wholesale pricing at all volume levels. 10% price beat on any competing quote. Contact [email protected]. Same-day shipping on orders before 3:00 PM EST. Full OEM and private label available across all three configurations.
Contact for Bulk 16 Panel Dip Card Orders, Wholesale Pricing and Private Label: 561-897-9238 | [email protected]
Check other product variations
for Multi Dip Cards
From everyday staples to specialty products:
- Multi Strips
- 5 Panel Dip Cards
- 10 Panel Dip Cards
- 12 Panel Dip Cards
- 14 Panel Dip Cards
- 19 Panel Dip Cards
10 Panel Dip
13 Dip Panel
12 Panel Dip
Dip Cards
Wholesale and Private Label 16 Panel Dip Cards: Bulk Pricing from $0.99, OEM and Custom Branding Available
12 Panel Now offers all three configurations of the 16 Panel Dip Card at bulk wholesale pricing. The TCA/KRA short date configuration starts at $0.99 per card, ideal for programs placing large orders they will use within that period. The KRA/KET and K2/TRA standard configurations start at $1.59 per card in regular stock with no expiry concern. Tiered volume pricing is available at every order level across all three configurations. All orders placed before 3:00 PM EST ship the same day. Free shipping on qualifying bulk purchases.
12 Panel Now guarantees a price beat on any current supplier's documented pricing for the same product. Send your current supplier's quote to [email protected] and we will match and beat it before your next order. All wholesale accounts receive dedicated account management and priority same-day shipping on standing orders. Mix all three 16 panel configurations on a single order and receive the same per-card volume pricing regardless of which configuration is ordered.
For programs currently purchasing both a 14 or 15 panel dip card and separate specialty strips alongside it, the 16 panel configurations consolidate up to six separate test events into a single $1.59 card — eliminating the multi-strip workflow cost while closing more detection gaps per collection event. For current volume pricing at your specific order quantity, contact 12 Panel Now at 561-897-9238.
OEM and Private Label — 16 Panel Dip Card
12 Panel Now manufactures the Serenity 16 Panel Dip Card line and offers full OEM and private label programs for distributors, treatment networks, correctional supply organizations, and drug testing companies that need a professionally branded 16 panel specialty dip card product at competitive manufacturing cost.
Private label options include:
- Custom foil pouch branding with your organization's logo, color scheme, and product name
- Custom card face printing with branded panel labeling and result interpretation guides
- Custom outer box and retail packaging for resale and distributor programs
- White-label configurations for national distributor networks
- OEM manufacturing to custom panel specifications — programs that need a 16 panel configuration other than the three standard options can specify custom panel combinations through the OEM program
The 16 panel configurations — particularly the KRA/KET and K2/TRA combinations — represent specialty product profiles that are not widely available from other multi-panel dip card manufacturers at this price point. Private label programs allow distributors and institutional supply buyers to bring these specialty products to their client networks under their own branding. Minimum order quantities, lead times, and custom setup fees are available on request from our private label team.
For wholesale accounts, private label setup, and OEM specifications contact:
12 Panel Now — Wholesale and Private Label
801 N Congress Ave, Boynton Beach FL 33426
561-897-9238 | [email protected]
12panelnow.com/wholesale | 12panelnow.com/private-label
What 12 Panel Now Offers:
220,000 Sq. Ft. Mega
Warehouse
We operate one of the largest drug-testing fulfillment centers in the country, stocked and ready to ship every day.
Lowest Wholesale Pricing. Highest Commissions. Period.
We aggressively price our products so you win more deals, while paying industry-leading commissions to our partners.
Same-Day Blind Drop Shipping
We ship directly to your customers — no branding, no invoices, no paper trail back to us. You keep the relationship. We do the heavy lifting.
Private Label Available
Want your own brand on the box? We’ve got you covered.
Build equity while selling proven products.
Real-Time Partner Portal
Track every order, commission, and customer in one clean dashboard. No guessing. No spreadsheets. Total transparency.
Where 16 Panel Dip Cards Are Used
| Setting | Best Card | Primary Applications | Why This Card |
| Pain Management Clinics | 16 Panel TCA/KRA | TCA co-prescription compliance alongside opioid compliance, Kratom self-management detection for patients using it as an adjunct or substitute for prescribed opioids, EtG alcohol monitoring, FEN for fentanyl adherence and diversion | TCA at 1000 ng/mL verifies compliance with co-prescribed tricyclic antidepressants — a requirement in many pain management protocols. KRA at 500 ng/mL detects kratom, increasingly used by pain patients as a legal opioid adjunct. The short date card at $0.99 offers exceptional value for programs placing large near-term orders through 12/13/26. |
| MAT and Treatment Programs | 16 Panel KRA/KET | Kratom monitoring for patients using it as an opioid substitute, Ketamine monitoring for patients receiving therapeutic infusions or misusing recreationally, EtG alcohol abstinence monitoring, FEN concurrent use detection alongside BUP and MTD compliance | KRA at 500 ng/mL and KET at 1000 ng/mL close two specific gaps documented in opioid treatment populations — legal substance workarounds and clinically prescribed substance monitoring. Per SAMHSA MAT guidelines, comprehensive concurrent substance monitoring including emerging substances is required. EtG covers the weekly alcohol inter-test interval. |
| Correctional Facilities | 16 Panel K2/TRA | K2 synthetic cannabinoid institutional contraband detection alongside Tramadol diversion screening, fentanyl supply contamination detection, alcohol monitoring, full stimulant and opioid baseline | K2 is documented as among the most significant contraband substances in US correctional institutions per NIDA data. Tramadol is a prescription opioid that passes every OPI screen and is documented in correctional diversion contexts. The K2/TRA card closes both institutional detection gaps simultaneously alongside FEN and EtG in a single $1.59 dip card. |
| Drug Courts and Probation | 16 Panel TCA/KRA or KRA/KET | Court-ordered comprehensive substance monitoring including Kratom legal-substance workaround detection, TCA monitoring where specified in supervision orders, or Ketamine detection for programs with documented hallucinogen misuse in their supervised population, alongside EtG alcohol abstinence monitoring and FEN | Per NADCP best practice standards, comprehensive monitoring including legal substance workarounds and emerging substances is recommended. Kratom is documented as a legal opioid substitute used by court-supervised individuals to evade standard drug screens. Both KRA cards address this gap. Card selection depends on whether TCA monitoring (pain/antidepressant) or Ketamine detection (dissociative misuse) is the secondary court priority. |
16 Panel Dip Card with Kratom and Ketamine: Why Treatment Programs Need Both KRA and KET Detection Alongside EtG and Fentanyl
The KRA/KET configuration of the 16 panel dip card from 12 Panel Now reflects two simultaneous developments in substance use patterns within opioid treatment populations. The first is the expanded availability and documented use of Kratom (Mitragyna speciosa) as a self-managed opioid substitute in MAT settings — a substance with mu-opioid receptor activity that produces opioid-like effects but passes every standard OPI, BUP, and MTD panel due to its distinct alkaloid structure. The second is the emergence of Ketamine as both a clinically prescribed antidepressant and a misused recreational substance increasingly documented in populations enrolled in opioid use disorder treatment.
Neither substance appears on any standard multi-panel drug test. A patient using both Kratom and Ketamine returns a completely negative result on every panel of a 28-panel cup. The KRA/KET configuration's dedicated panels — KRA at 500 ng/mL using a Kratom alkaloid-specific antibody, and KET at 1000 ng/mL using a ketamine-specific antibody — provide the only available point-of-care detection for both substances in a single card alongside EtG/300 for alcohol monitoring and FEN/20 for fentanyl concurrent use detection. Per NIDA herbal drug research, kratom's opioid dependence potential and increasing presence in treatment populations makes dedicated KRA detection a clinical monitoring priority. At $1.59 per card in bulk with same-day shipping, this card is the practical single-card solution for programs dealing with polydrug-using populations where Kratom and Ketamine are documented alongside fentanyl and alcohol use.
16 Panel vs 14 Panel Dip Card: What Changes, What Stays the Same, and When to Upgrade
The upgrade from a 14 panel to a 16 panel dip card adds exactly two specialty panels while retaining every panel from the 14-panel baseline. EtG and FEN are already present on both the 14 and 16 panel cards. The 14-panel baseline (AMP, BAR, BUP, BZO, COC, EtG, FEN, MDMA, MET, MTD, OPI/MOR, OXY, PCP, THC) is retained in full on every 16 panel card. The 16 panel card then adds two additional specialty substances depending on configuration: TCA and KRA, KET and KRA, or K2 and TRA.
The decision to upgrade from 14 to 16 panel is straightforward: does the program need to detect either (a) Kratom and TCA, (b) Kratom and Ketamine, or (c) K2 and Tramadol in their screening population? If any of those pairings match the program's documented substance monitoring gaps, the 16 panel card at $1.59 — compared to the 14 panel card at $1.39 — closes those gaps for $0.20 additional per card. The $0.20 difference per card is significantly less than the cost of adding standalone Kratom, Ketamine, K2, or Tramadol single-panel strips to supplement a 14 panel card. For programs needing coverage of all six specialty substances (KRA, KET, K2, TRA, and the GAB and other substances), see the 19 panel dip card, which integrates the comprehensive specialty-panel profile at $1.05 per card in bulk. Contact 12 Panel Now at 561-897-9238 to discuss which configuration matches your program's specific requirements.
What Does “Forensic Use Only” Mean for 16 Panel Dip Cards?
- 1. What It Means
A “Forensic Use Only” label indicates that the 10 panel dip card:
Has not undergone FDA 510(k) clearance as a medical diagnostic device
Is intended for screening and compliance monitoring purposes only
Is designed for use in controlled environments such as workplace, legal, or institutional testing programs
16 Panel Dip Card frequently asked questions
If you need to monitor substances such as Kratom and Ketamine in addition to standard drug screening, the KRA/KET configuration is generally the best fit for treatment and recovery programs.
An invalid result means the test did not function correctly and should be repeated with a new device and specimen.
Yes. Depending on the configuration selected, it can screen for additional substances such as Kratom, Ketamine, K2, Tramadol, or Tricyclic Antidepressants.
Yes. Many probation departments and drug courts use expanded-panel tests to monitor a wider range of substances.
Results are available within a few minutes, making it suitable for on-site screening.
A 16-panel test adds two specialty drug panels while keeping the full 14-panel baseline, giving broader coverage without running separate tests.
Yes. Employers often use multi-panel dip cards for pre-employment, random, and reasonable-suspicion testing programs.
The K2/TRA configuration is designed for programs that want coverage for both synthetic cannabinoids and Tramadol.
No. The dip-card format is designed for rapid screening without specialized equipment.
It is commonly used in monitoring programs, but organizations should follow their own clinical and regulatory requirements.
Yes. Expanded-panel testing is frequently used in correctional settings where additional substances may be a concern.
Many suppliers allow mixed orders so organizations can stock multiple configurations based on their screening needs.
It detects drugs and metabolites within their respective detection windows, which vary by substance and individual factors.
The TCA/KRA configuration is often selected by pain management programs because it includes both Tricyclic Antidepressants and Kratom detection.
No. Screening results are generally considered preliminary and may require laboratory confirmation.
They should remain sealed and be stored according to the manufacturer's recommended temperature and handling guidelines.
Yes. The 16-panel configurations include alcohol metabolite screening in addition to drug testing.
Most organizations can administer the test using the provided instructions, though internal training procedures may still be used.
Common users include employers, treatment centers, healthcare facilities, correctional institutions, and compliance-monitoring programs.
Yes. Many manufacturers offer OEM and private-label options for distributors and organizations that want custom branding.
Perfect for brochures, menus, and promotional materials, these cards combine functionality with a polished, professional look. Their unique folding design not only grabs attention but also enhances user experience, helping businesses communicate their message effectively while leaving a memorable impression.
